It is believed that loss of SST synthesis in mucosa of patients with colon cancer might contribute to enhanced cell proliferation and promoter hypermethylation, possibly responsible for epigenetically reduced expression of SST in CRC. The gene discussed is SST; the disease is malignant colon neoplasm.